AIP and neoplasm: Among these, seven candidates were selected for further investigation for their roles in oncogenic and tumor-suppressive pathways: AIP (37), CACYBP (38), δ-catenin (23, 30), ING3 (39), TNK1 (40), YAP, and AMOT (41) (Fig. 1B, red dots).